Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

ABO-incompatible heart transplantation: a perfusion strategy.

C Foreman1, C Gruenwald, L West

  • 1Cardiovascular Perfusion Department, The Hospital for Sick Children, Toronto, Canada.

Perfusion
|April 10, 2004
PubMed
Summary

Infants with fatal heart conditions can now receive transplants despite blood type differences. This innovative approach significantly reduces waiting list mortality by overcoming ABO incompatibility barriers.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Developing a More Tailored Approach to Patient and Public Involvement with Children and Families in Pediatric Clinical Research: Lessons Learned.

Therapeutic innovation & regulatory science·2022
Same author

Hemorrhage after Pulp Extirpation.

The Dental register·2021
Same author

Estimation of External Dose Rates to Hotel Workers from bed linens Contaminated by 131I Patients.

Health physics·2019
Same author

Which aspects of health care are most valued by people living with HIV in high-income countries? A systematic review.

BMC health services research·2016
Same author

The XIIIth Banff Conference on Allograft Pathology: The Banff 2015 Heart Meeting Report: Improving Antibody-Mediated Rejection Diagnostics: Strengths, Unmet Needs, and Future Directions.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016
Same author

Maize yield response to a phosphorus-solubilizing microbial inoculant in field trials.

The Journal of agricultural science·2015

Area of Science:

  • Cardiology
  • Immunology
  • Transplantation Surgery

Background:

  • Infants with fatal cardiac disease face high mortality rates due to donor heart shortages.
  • Traditional heart transplantation requires ABO blood group compatibility, limiting the donor pool.

Purpose of the Study:

  • To investigate the feasibility and outcomes of ABO-incompatible heart transplantation in infants.
  • To reduce mortality rates among infants awaiting heart transplants by expanding donor options.

Main Methods:

  • Implemented a modified cardiopulmonary bypass (CPB) technique to reduce anti-A and anti-B antibodies in infants.
  • Performed ABO-incompatible heart transplants on 16 infants under 14 months of age.
  • Utilized plasma depletion and reinfusion of packed red blood cells during CPB.

Related Experiment Videos

Main Results:

  • Achieved an 87% survival rate in infants undergoing ABO-incompatible heart transplantation.
  • Reduced the mortality rate of infants on the waiting list from 58% to 10%.

Conclusions:

  • ABO-incompatible heart transplantation is a viable strategy to improve survival in infants with fatal cardiac disease.
  • Infants' immunologic immaturity contributes to the success of ABO-incompatible transplants.
  • Expanding heart transplantation beyond ABO compatibility can decrease waiting times and save lives.